Emergency Use of Adoptive Immunotherapy With CMV-Specific T Cells After Donor Bone Marrow Transplant of an Infant With Immunodeficiency Syndrome and CMV Infection
Expanded access is no longer available for this treatment.
( No accrual )
Study NCT00547235
Information provided by Fred Hutchinson Cancer Research Center
First Received on October 19, 2007.
Last Updated on August 23, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
